Related Experiment Video
Updated: Nov 8, 2025
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
The Role of Using Red-Topped - Non-Additive-Containing - Collecting Tube in Diagnosing Pseudohyperkalemia in Chronic
Ahmed Abdulrahim1, Mohamedanwar Ghandour2, Abu-Bekr Mohamed1
1Internal Medicine, Wayne State University Detroit Medical Center, Detroit, USA.
Insights
Pseudohyperkalemia, a common issue in chronic lymphocytic leukemia (CLL), challenges clinicians. Differentiating true hyperkalemia from pseudohyperkalemia is crucial to avoid unnecessary treatments and potential harm.
Area of Science:
- Hematology
- Clinical Chemistry
Background:
- Pseudohyperkalemia is an increasingly recognized clinical presentation in patients with chronic lymphocytic leukemia (CLL).
- Accurate differentiation between true hyperkalemia and pseudohyperkalemia poses a significant diagnostic challenge for clinicians.
Abstract:
Pseudohyperkalemia in the context of chronic lymphocytic leukemia (CLL) is becoming a common clinical presentation in our daily practice, yet the recognition and the overall approach to this condition remains a challenge as clinicians ponder on whether it's a true rise of serum potassium or not, weighing the risk-benefit ratio of giving the full anti-hyperkalemia measures, dreading the potential iatrogenic hypokalemia if it proves to be a pseudohyperkalemia instead.
More Related Videos
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
11:39Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019